Skip to main content
Erschienen in: Endocrine 2/2014

01.03.2014 | Original Article

Serum levels of IgG and IgG4 in Hashimoto thyroiditis

verfasst von: Sachiko-Tsukamoto Kawashima, Tetsuya Tagami, Kanako Nakao, Kazutaka Nanba, Tamiko Tamanaha, Takeshi Usui, Mitsuhide Naruse, Sachiko Minamiguchi, Yusuke Mori, Jun Tsuji, Issei Tanaka, Akira Shimatsu

Erschienen in: Endocrine | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract.

Although IgG4-related disease is characterized by extensive infiltration of IgG4-positive plasma cells and lymphocytes of various organs, the details of this systemic disease are still unclear. We screened serum total IgG levels in the patients with Hashimoto thyroiditis (HT) to illustrate the prevalence of IgG4-related thyroiditis in HT. Twenty-four of 94 patients with HT (25.5 %) had elevated serum IgG levels and their serum IgG4 was measured. Five of the 24 cases had more than 135 mg/dL of IgG4, which is the serum criterion of IgG4-related disease. One was a female patient who was initially treated as Graves’ disease and rapidly developed a firm goiter and hypothyroidism. The biopsy of her thyroid gland revealed that follicular cells were atrophic with squamous metaplasia, replaced with fibrosis, which was compatible with the fibrous variant of HT. Immunohistochemical examination revealed diffuse infiltration of IgG4-positive plasma cells, and the serum IgG4 level was 179 mg/dL. The levels of IgG and IgG4 were positively correlated with the titers of anti-thyroglobulin antibody or anti-thyroid peroxidase antibody. In conclusion, at least a small portion of patients with HT with high titers of anti-thyroid antibodies may overlap the IgG4-related thyroiditis.
Literatur
1.
Zurück zum Zitat Y. Masaki, L. Dong, N. Kurose, K. Kitagawa, Y. Morikawa, M. Yamamoto, H. Takahashi, Y. Shinomura, K. Imai, T. Saeki, A. Azumi, S. Nakada, E. Sugiyama, S. Matsui, T. Origuchi, S. Nishiyama, I. Nishimori, T. Nojima, K. Yamada, M. Kawano, Y. Zen, M. Kaneko, K. Miyazaki, K. Tsubota, K. Eguchi, K. Tomoda, T. Sawaki, T. Kawanami, M. Tanaka, T. Fukushima, S. Sugai, H. Umehara, Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann. Rheum. Dis. 68, 1310–1315 (2009)PubMedCrossRef Y. Masaki, L. Dong, N. Kurose, K. Kitagawa, Y. Morikawa, M. Yamamoto, H. Takahashi, Y. Shinomura, K. Imai, T. Saeki, A. Azumi, S. Nakada, E. Sugiyama, S. Matsui, T. Origuchi, S. Nishiyama, I. Nishimori, T. Nojima, K. Yamada, M. Kawano, Y. Zen, M. Kaneko, K. Miyazaki, K. Tsubota, K. Eguchi, K. Tomoda, T. Sawaki, T. Kawanami, M. Tanaka, T. Fukushima, S. Sugai, H. Umehara, Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann. Rheum. Dis. 68, 1310–1315 (2009)PubMedCrossRef
2.
Zurück zum Zitat H. Umehara, K. Okazaki, Y. Masaki, M. Kawano, M. Yamamoto, T. Saeki, S. Matsui, T. Yoshino, S. Nakamura, S. Kawa, H. Hamano, T. Kamisawa, T. Shimosegawa, A. Shimatsu, S. Nakamura, T. Ito, K. Notohara, T. Sumida, Y. Tanaka, T. Mimori, T. Chiba, M. Mishima, T. Hibi, H. Tsubouchi, K. Inui, H. Ohara, Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod. Rheumatol. 22, 21–30 (2012)PubMedCrossRef H. Umehara, K. Okazaki, Y. Masaki, M. Kawano, M. Yamamoto, T. Saeki, S. Matsui, T. Yoshino, S. Nakamura, S. Kawa, H. Hamano, T. Kamisawa, T. Shimosegawa, A. Shimatsu, S. Nakamura, T. Ito, K. Notohara, T. Sumida, Y. Tanaka, T. Mimori, T. Chiba, M. Mishima, T. Hibi, H. Tsubouchi, K. Inui, H. Ohara, Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod. Rheumatol. 22, 21–30 (2012)PubMedCrossRef
3.
Zurück zum Zitat H. Hamano, S. Kawa, A. Horiuchi, H. Unno, N. Furuya, T. Akamatsu, M. Fukushima, T. Nikaido, K. Nakayama, N. Usuda, K. Kiyosawa, High serum IgG4 concentrations in patients with sclerosing pancreatitis. N. Engl. J. Med. 344, 732–738 (2001)PubMedCrossRef H. Hamano, S. Kawa, A. Horiuchi, H. Unno, N. Furuya, T. Akamatsu, M. Fukushima, T. Nikaido, K. Nakayama, N. Usuda, K. Kiyosawa, High serum IgG4 concentrations in patients with sclerosing pancreatitis. N. Engl. J. Med. 344, 732–738 (2001)PubMedCrossRef
4.
Zurück zum Zitat H. Hamano, S. Kawa, Y. Ochi, H. Unno, N. Shiba, M. Wajiki, K. Nakazawa, H. Shimojo, K. Kiyosawa, Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 359, 1403–1404 (2002)PubMedCrossRef H. Hamano, S. Kawa, Y. Ochi, H. Unno, N. Shiba, M. Wajiki, K. Nakazawa, H. Shimojo, K. Kiyosawa, Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 359, 1403–1404 (2002)PubMedCrossRef
5.
Zurück zum Zitat Y. Zen, T. Fujii, Y. Sato, S. Masuda, Y. Nakanuma, Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod. Pathol. 20, 884–894 (2007)PubMedCrossRef Y. Zen, T. Fujii, Y. Sato, S. Masuda, Y. Nakanuma, Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod. Pathol. 20, 884–894 (2007)PubMedCrossRef
6.
Zurück zum Zitat Y. Sato, K. Notohara, M. Kojima, K. Takata, Y. Masaki, T. Yoshino, IgG4-related disease: historical overview and pathology of hematological disorders. Pathol. Int. 60, 247–258 (2010)PubMedCrossRef Y. Sato, K. Notohara, M. Kojima, K. Takata, Y. Masaki, T. Yoshino, IgG4-related disease: historical overview and pathology of hematological disorders. Pathol. Int. 60, 247–258 (2010)PubMedCrossRef
7.
Zurück zum Zitat Y. Zen, S. Kitagawa, H. Minato, H. Kuruyama, K. Katayanagi, S. Masuda, H. Niwa, M. Fujimura, Y. Nakanuma, IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum. Pathol. 36, 710–717 (2005)PubMedCrossRef Y. Zen, S. Kitagawa, H. Minato, H. Kuruyama, K. Katayanagi, S. Masuda, H. Niwa, M. Fujimura, Y. Nakanuma, IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum. Pathol. 36, 710–717 (2005)PubMedCrossRef
8.
Zurück zum Zitat Y. Sato, K. Ohshima, K. Ichimura, M. Sato, I. Yamadori, T. Tanaka, K. Takata, T. Morito, E. Kondo, T. Yoshino, Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol. Int. 58, 465–470 (2008)PubMedCrossRef Y. Sato, K. Ohshima, K. Ichimura, M. Sato, I. Yamadori, T. Tanaka, K. Takata, T. Morito, E. Kondo, T. Yoshino, Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol. Int. 58, 465–470 (2008)PubMedCrossRef
9.
Zurück zum Zitat S. Takeda, J. Haratake, T. Kasai, C. Takaeda, E. Takazakura, IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol. Dial. Transplant. 19, 474–476 (2004)PubMedCrossRef S. Takeda, J. Haratake, T. Kasai, C. Takaeda, E. Takazakura, IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol. Dial. Transplant. 19, 474–476 (2004)PubMedCrossRef
10.
Zurück zum Zitat A. Shimatsu, Y. Oki, I. Fujisawa, T. Sano, Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr. J. 56, 1033–1041 (2009)PubMedCrossRef A. Shimatsu, Y. Oki, I. Fujisawa, T. Sano, Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr. J. 56, 1033–1041 (2009)PubMedCrossRef
11.
Zurück zum Zitat D.S.A. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine 42, 252–265 (2012)PubMedCrossRef D.S.A. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine 42, 252–265 (2012)PubMedCrossRef
12.
Zurück zum Zitat K. Komatsu, H. Hamano, Y. Ochi, M. Takayama, T. Muraki, K. Yoshizawa, A. Sakurai, M. Ota, S. Kawa, High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig. Dis. Sci. 50, 1052–1057 (2005)PubMedCrossRef K. Komatsu, H. Hamano, Y. Ochi, M. Takayama, T. Muraki, K. Yoshizawa, A. Sakurai, M. Ota, S. Kawa, High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig. Dis. Sci. 50, 1052–1057 (2005)PubMedCrossRef
13.
Zurück zum Zitat K. Kakudo, Y. Li, E. Taniguchi, I. Mori, T. Ozaki, E. Nishihara, F. Matsuzuka, A. Miyauchi, IgG4-related disease of the thyroid glands. Endocr. J. 59, 273–281 (2012)PubMedCrossRef K. Kakudo, Y. Li, E. Taniguchi, I. Mori, T. Ozaki, E. Nishihara, F. Matsuzuka, A. Miyauchi, IgG4-related disease of the thyroid glands. Endocr. J. 59, 273–281 (2012)PubMedCrossRef
14.
Zurück zum Zitat Y. Li, Y. Bai, Z. Liu, T. Ozaki, E. Taniguchi, I. Mori, K. Nagayama, H. Nakamura, K. Kakudo, Immunohistochemistry of IgG4 can help subclassify Hashimoto’s autoimmune thyroiditis. Pathol. Int. 59, 636–641 (2009)PubMedCrossRef Y. Li, Y. Bai, Z. Liu, T. Ozaki, E. Taniguchi, I. Mori, K. Nagayama, H. Nakamura, K. Kakudo, Immunohistochemistry of IgG4 can help subclassify Hashimoto’s autoimmune thyroiditis. Pathol. Int. 59, 636–641 (2009)PubMedCrossRef
15.
Zurück zum Zitat Y. Li, E. Nishihara, M. Hirooka, E. Taniguchi, A. Miyauchi, K. Kakudo, Distinct clinical serological and sonographic characteristics of Hashimoto’s thyroiditis based with and without IgG4-positive plasma cells. J. Clin. Endocrinol. Metab. 95, 1309–1317 (2010)PubMedCrossRef Y. Li, E. Nishihara, M. Hirooka, E. Taniguchi, A. Miyauchi, K. Kakudo, Distinct clinical serological and sonographic characteristics of Hashimoto’s thyroiditis based with and without IgG4-positive plasma cells. J. Clin. Endocrinol. Metab. 95, 1309–1317 (2010)PubMedCrossRef
16.
Zurück zum Zitat Y. Li, G. Zhou, T. Ozaki, E. Nishihara, F. Matsuzuka, Y. Bai, Z. Liu, E. Taniguchi, A. Miyauchi, K. Kakudo, Distinct histopathological features of Hashimoto’s thyroiditis with respect to IgG4-related disease. Mod. Pathol. 25, 1086–1097 (2012)PubMedCrossRef Y. Li, G. Zhou, T. Ozaki, E. Nishihara, F. Matsuzuka, Y. Bai, Z. Liu, E. Taniguchi, A. Miyauchi, K. Kakudo, Distinct histopathological features of Hashimoto’s thyroiditis with respect to IgG4-related disease. Mod. Pathol. 25, 1086–1097 (2012)PubMedCrossRef
17.
Zurück zum Zitat S.M. Katz, A.L. Vickery Jr, The fibrous variant of Hashimoto’s thyroiditis. Hum. Pathol. 5, 161–170 (1974)PubMedCrossRef S.M. Katz, A.L. Vickery Jr, The fibrous variant of Hashimoto’s thyroiditis. Hum. Pathol. 5, 161–170 (1974)PubMedCrossRef
18.
Zurück zum Zitat D.E. Comings, K.B. Skubi, J. Van Eyes, A.G. Motulsky, Familial multifocal fibrosclerosis. Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedel’s thyroiditis, and pseudotumor of the orbit may be different manifestations of a single disease. Ann. Intern. Med. 66, 884–892 (1967)PubMedCrossRef D.E. Comings, K.B. Skubi, J. Van Eyes, A.G. Motulsky, Familial multifocal fibrosclerosis. Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedel’s thyroiditis, and pseudotumor of the orbit may be different manifestations of a single disease. Ann. Intern. Med. 66, 884–892 (1967)PubMedCrossRef
19.
Zurück zum Zitat B.M.K.L. Riedel, Die cronische, zur Bildung eisenharter Tumoren fuhrende Entzundung der Schilddruse. Verh. Dtsch. Ces. Chir. 25, 101–105 (1896) B.M.K.L. Riedel, Die cronische, zur Bildung eisenharter Tumoren fuhrende Entzundung der Schilddruse. Verh. Dtsch. Ces. Chir. 25, 101–105 (1896)
20.
Zurück zum Zitat H.R. Harach, E.D. Williams, Fibrous thyroiditis—an immunopathological study. Histopathology 7, 739–751 (1983)PubMedCrossRef H.R. Harach, E.D. Williams, Fibrous thyroiditis—an immunopathological study. Histopathology 7, 739–751 (1983)PubMedCrossRef
21.
Zurück zum Zitat M. Dahlgren, A. Khosroshahi, G.P. Nielsen, V. Deshpande, J.H. Stone, Riedel’s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res. (Hoboken) 62, 1312–1318 (2010)CrossRef M. Dahlgren, A. Khosroshahi, G.P. Nielsen, V. Deshpande, J.H. Stone, Riedel’s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res. (Hoboken) 62, 1312–1318 (2010)CrossRef
22.
Zurück zum Zitat M. Pusztaszeri, F. Triponez, J.C. Pache, M. Bongiovanni, Riedel’s thyroiditis with increased IgG4 plasma cells: evidence for an underlying IgG4-related sclerosing disease? Thyroid 22, 964–968 (2012)PubMedCrossRef M. Pusztaszeri, F. Triponez, J.C. Pache, M. Bongiovanni, Riedel’s thyroiditis with increased IgG4 plasma cells: evidence for an underlying IgG4-related sclerosing disease? Thyroid 22, 964–968 (2012)PubMedCrossRef
23.
Zurück zum Zitat J.W. Goodman, Antigen presentation and the major histocompatibility complex, in Basic and Clinical Immunology, ed. by D.P. Sites (Lange Med Books, New York, 1994), pp. 58–67 J.W. Goodman, Antigen presentation and the major histocompatibility complex, in Basic and Clinical Immunology, ed. by D.P. Sites (Lange Med Books, New York, 1994), pp. 58–67
24.
Zurück zum Zitat P. Van der Zee Swieten, R.C. Aalberse, Inhibition of complement activation by IgG4 antibodies. Clin. Exp. Immunol. 64, 415–422 (1986) P. Van der Zee Swieten, R.C. Aalberse, Inhibition of complement activation by IgG4 antibodies. Clin. Exp. Immunol. 64, 415–422 (1986)
25.
26.
Zurück zum Zitat J. Punnonen, G. Aversa, B.G. Cocks, A.N. McKenzie, S. Menon, G. Zurawski, R. de Waal Malefyt, J.E. de Vries, Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. U.S.A. 90, 3730–3734 (1993)PubMedCentralPubMedCrossRef J. Punnonen, G. Aversa, B.G. Cocks, A.N. McKenzie, S. Menon, G. Zurawski, R. de Waal Malefyt, J.E. de Vries, Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. U.S.A. 90, 3730–3734 (1993)PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat R.C. Aalberse, F. Van Milligen, K.Y. Tan, S.O. Stapel, Allergen-specific IgG4 in atopic disease. Allergy 48, 559–569 (1993)PubMedCrossRef R.C. Aalberse, F. Van Milligen, K.Y. Tan, S.O. Stapel, Allergen-specific IgG4 in atopic disease. Allergy 48, 559–569 (1993)PubMedCrossRef
28.
Zurück zum Zitat R. Hussain, R.W. Poindexter, E.A. Ottesen, Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J. Immunol. 148, 2731–2737 (1992)PubMed R. Hussain, R.W. Poindexter, E.A. Ottesen, Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J. Immunol. 148, 2731–2737 (1992)PubMed
29.
Zurück zum Zitat C.C. Jones, R.G. Hamilton, R.E. Jordon, Subclass distribution of human IgG autoantibodies in pemphigus. J. Clin. Immunol. 8, 43–49 (1988)PubMedCrossRef C.C. Jones, R.G. Hamilton, R.E. Jordon, Subclass distribution of human IgG autoantibodies in pemphigus. J. Clin. Immunol. 8, 43–49 (1988)PubMedCrossRef
30.
Zurück zum Zitat Y. Futei, M. Amagai, K. Ishii, K. Kuroda-Kinoshita, K. Ohya, T. Nishikawa, Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus. J. Dermatol. Sci. 26, 55–61 (2001)PubMedCrossRef Y. Futei, M. Amagai, K. Ishii, K. Kuroda-Kinoshita, K. Ohya, T. Nishikawa, Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus. J. Dermatol. Sci. 26, 55–61 (2001)PubMedCrossRef
31.
Zurück zum Zitat V. Deshpande, Y. Zen, J.K. Chan, E.E. Yi, Y. Sato, T. Yoshino, G. Klöppel, J.G. Heathcote, A. Khosroshahi, J.A. Ferry, R.C. Aalberse, D.B. Bloch, W.R. Brugge, A.C. Bateman, M.N. Carruthers, S.T. Chari, W. Cheuk, L.D. Cornell, C. Fernandez-Del Castillo, D.G. Forcione, D.L. Hamilos, T. Kamisawa, S. Kasashima, S. Kawa, M. Kawano, G.Y. Lauwers, Y. Masaki, Y. Nakanuma, K. Notohara, K. Okazaki, J.K. Ryu, T. Saeki, D.V. Sahani, T.C. Smyrk, J.R. Stone, M. Takahira, G.J. Webster, M. Yamamoto, G. Zamboni, H. Umehara, J.H. Stone, Consensus statement on the pathology of IgG4-related disease. Mod. Pathol. 25, 1181–1192 (2012)PubMedCrossRef V. Deshpande, Y. Zen, J.K. Chan, E.E. Yi, Y. Sato, T. Yoshino, G. Klöppel, J.G. Heathcote, A. Khosroshahi, J.A. Ferry, R.C. Aalberse, D.B. Bloch, W.R. Brugge, A.C. Bateman, M.N. Carruthers, S.T. Chari, W. Cheuk, L.D. Cornell, C. Fernandez-Del Castillo, D.G. Forcione, D.L. Hamilos, T. Kamisawa, S. Kasashima, S. Kawa, M. Kawano, G.Y. Lauwers, Y. Masaki, Y. Nakanuma, K. Notohara, K. Okazaki, J.K. Ryu, T. Saeki, D.V. Sahani, T.C. Smyrk, J.R. Stone, M. Takahira, G.J. Webster, M. Yamamoto, G. Zamboni, H. Umehara, J.H. Stone, Consensus statement on the pathology of IgG4-related disease. Mod. Pathol. 25, 1181–1192 (2012)PubMedCrossRef
32.
Zurück zum Zitat G. Torrigiani, I.M. Roitt, D. Doniach, Quantitative distribution of human thyroglobulin autoantibodies in different immunoglobulin classes. Clin. Exp. Immunol. 3, 621–630 (1968)PubMedCentralPubMed G. Torrigiani, I.M. Roitt, D. Doniach, Quantitative distribution of human thyroglobulin autoantibodies in different immunoglobulin classes. Clin. Exp. Immunol. 3, 621–630 (1968)PubMedCentralPubMed
33.
Zurück zum Zitat L. Portmann, N. Hamada, G. Heinrich, L.J. DeGroot, Anti-thyroid peroxidase antibody in patients with autoimmune thyroid disease: possible identity with anti-microsomal antibody. J. Clin. Endocrinol. Metab. 61, 1001–1003 (1985)PubMedCrossRef L. Portmann, N. Hamada, G. Heinrich, L.J. DeGroot, Anti-thyroid peroxidase antibody in patients with autoimmune thyroid disease: possible identity with anti-microsomal antibody. J. Clin. Endocrinol. Metab. 61, 1001–1003 (1985)PubMedCrossRef
34.
Zurück zum Zitat P. Caturegli, R.C. Kuppers, S. Mariotti, C.L. Burek, A. Pinchera, P.W. Ladenson, N.R. Rose, IgG subclass distribution of thyroglobulin antibodies in patients with thyroid disease. Clin. Exp. Immunol. 98, 464–469 (1994)PubMedCentralPubMedCrossRef P. Caturegli, R.C. Kuppers, S. Mariotti, C.L. Burek, A. Pinchera, P.W. Ladenson, N.R. Rose, IgG subclass distribution of thyroglobulin antibodies in patients with thyroid disease. Clin. Exp. Immunol. 98, 464–469 (1994)PubMedCentralPubMedCrossRef
35.
Zurück zum Zitat S. Mariotti, G.F. del Prete, C. Mastromauro, M. de Carli, S. Romagnani, M. Ricci, A. Pinchera, The autoimmune infiltrate of Basedow’s disease: analysis at clonal level and comparison with Hashimoto’s thyroiditis. Exp. Clin. Endocrinol. 97, 139–146 (1991)PubMedCrossRef S. Mariotti, G.F. del Prete, C. Mastromauro, M. de Carli, S. Romagnani, M. Ricci, A. Pinchera, The autoimmune infiltrate of Basedow’s disease: analysis at clonal level and comparison with Hashimoto’s thyroiditis. Exp. Clin. Endocrinol. 97, 139–146 (1991)PubMedCrossRef
36.
Zurück zum Zitat J. Guo, J.C. Jaume, B. Rapoport, S.M. McLachlan, Recombinant thyroid peroxidase-specific Fab converted to immunoglobulin G (IgG) molecules: evidence for thyroid cell damage by IgG1, but not IgG4, autoantibodies. J. Clin. Endocrinol. Metab. 82, 925–931 (1997)PubMed J. Guo, J.C. Jaume, B. Rapoport, S.M. McLachlan, Recombinant thyroid peroxidase-specific Fab converted to immunoglobulin G (IgG) molecules: evidence for thyroid cell damage by IgG1, but not IgG4, autoantibodies. J. Clin. Endocrinol. Metab. 82, 925–931 (1997)PubMed
37.
Zurück zum Zitat L.D. Xie, Y. Gao, M.R. Li, G.Z. Lu, X.H. Guo, Distribution of immunoglobulin G subclasses of anti-thyroid peroxidase antibody in sera from patients with Hashimoto’s thyroiditis with different thyroid functional status. Clin. Exp. Immunol. 154, 172–176 (2008)PubMedCentralPubMedCrossRef L.D. Xie, Y. Gao, M.R. Li, G.Z. Lu, X.H. Guo, Distribution of immunoglobulin G subclasses of anti-thyroid peroxidase antibody in sera from patients with Hashimoto’s thyroiditis with different thyroid functional status. Clin. Exp. Immunol. 154, 172–176 (2008)PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Y. Kohno, M. Kijima, F. Yamaguchi, K. Saito, H. Tsunoo, T. Hosoya, H. Niimi, Comparison of the IgG subtype distribution of anti-thyroid peroxidase antibodies in healthy subjects with that in patients with chronic thyroiditis. Endocr. J. 40, 317–321 (1993)PubMedCrossRef Y. Kohno, M. Kijima, F. Yamaguchi, K. Saito, H. Tsunoo, T. Hosoya, H. Niimi, Comparison of the IgG subtype distribution of anti-thyroid peroxidase antibodies in healthy subjects with that in patients with chronic thyroiditis. Endocr. J. 40, 317–321 (1993)PubMedCrossRef
39.
Zurück zum Zitat H. Hashimoto, Zur Kenntnis der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa). Archiv für klinische Chirurgie Berlin 97, 219–248 (1912) H. Hashimoto, Zur Kenntnis der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa). Archiv für klinische Chirurgie Berlin 97, 219–248 (1912)
Metadaten
Titel
Serum levels of IgG and IgG4 in Hashimoto thyroiditis
verfasst von
Sachiko-Tsukamoto Kawashima
Tetsuya Tagami
Kanako Nakao
Kazutaka Nanba
Tamiko Tamanaha
Takeshi Usui
Mitsuhide Naruse
Sachiko Minamiguchi
Yusuke Mori
Jun Tsuji
Issei Tanaka
Akira Shimatsu
Publikationsdatum
01.03.2014
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2014
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-9988-9

Weitere Artikel der Ausgabe 2/2014

Endocrine 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.